financial results
Enzo Biochem Q3 Revenues Nearly Double on Clinical Lab Testing Demand
The recent quarter reflected growing demand for testing services and a steady improvement in sales of its products and services, the firm said.
GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April
The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.
Agilent Q2 Revenues Rise 23 Percent
The company's revenues rose to $1.53 billion from $1.24 billion and beat the analysts' average estimate of $1.40 billion.
Burning Rock Q1 Revenues Rise 58 Percent
The Guangzhou, China-based company said it tested 7,716 patients through its central lab during the quarter, driving its overall revenue growth.
Genetron Health Q1 Revenues up 20 Percent
Driven by LDT sales, especially of its early liver cancer screening assay, HCCscreen, the company's core oncology business grew 53 percent year over year.
May 20, 2021
Olink Q1 Revenues Rise 70 Percent
May 18, 2021
Akoya Biosciences Q1 Revenues Rise 11 Percent
May 13, 2021
Bionano Genomics Q1 Revenues Almost Triple
May 13, 2021
Progenity Q1 Revenues up 46 Percent
May 12, 2021
Interpace Biosciences Q1 Revenues Up 8 Percent
May 11, 2021
Biodesix Q1 Revenues Soar on COVID-19 Testing
May 10, 2021
NanoString Technologies Q1 Revenues Grow 19 Percent
May 10, 2021
Castle Biosciences Q1 Revenues Up 31 Percent
May 10, 2021